期刊文献+

血管紧张素Ⅱ-1型受体拮抗剂对阿霉素肾病大鼠干预效果的实验研究 被引量:1

Intervention of Angiotensin Ⅱ receptor antagonist valsartan on rat of adrimycin nephrosis
下载PDF
导出
摘要 目的 探讨血管紧张素Ⅱ 1受体拮抗剂 (AT1RA)缬沙坦对大鼠肾病综合征病理及相关临床指标的干预作用及可能机制。方法 采用阿霉素肾病 (AN)模型 ,将大鼠分为阿霉素肾病组和缬沙坦及苯拉普利治疗组 ,检测大鼠 2 4h尿蛋白排泄量、血肌酐、尿素氮及其他生化指标 ,并取肾脏进行光镜及电镜检查 ,放射免疫分析法测定血浆及肾组织血管紧张素Ⅱ含量 ,并设正常对照组。结果 缬沙坦及苯拉普利可降低阿霉素肾病大鼠的蛋白尿排泄 ,改善生化指标。结论 缬沙坦对阿霉素肾病大鼠的肾脏具有保护效应 ,减轻肾损伤 。 Objective To evaluate the effects of valsartan,specific antagonist of angiotensin Ⅱ receptors on kidney of rat with adrimycin nephrosis(AN).Methods The adrimycin nephrosis rats were treated with valsartan and benazepril.24 hour urine protein excretion,serum creatinine and blood urea nitrogen as well as renal morphological lesions were observed;angiotensin Ⅱ concentration serum and renal tissue was detected by RIA.Results In valsartan and benazepril treated rats,the proteinuria decreased compared with the untreated rats.Conclusion Valsartan partly reduces the urine protein excretion and significantly prevents renal injury in AN rats.
出处 《江苏医药》 CAS CSCD 北大核心 2004年第4期284-286,共3页 Jiangsu Medical Journal
基金 江苏省卫生厅课题 (Z990 5 )
关键词 血管紧张素Ⅱ 阿霉素肾病 大鼠 缬沙坦 肾病综合征 病理特点 Adrimycin nephrosis Valsartan Benazepril
  • 相关文献

参考文献6

  • 1Wu LL,Yang N,Roe CJ,et al.Macrophage and myofibroblast proliferation in remnant kidney role of angiotensin Ⅱ.Kidney Int,1997,(52 Supple)63 :S221-S225.
  • 2Matsusaka T,Ichikawa I.Biological functions of angiotensin and its receptor.Annu Rev Physiol,1997,29 :395-412.
  • 3Stawn WB,Gallagher PE,Tallant EA,et al.Angiotensin Ⅱ AT1receptor blockade inhibits monocyte activation and adherence in transgenic(mRen-2 ) 27rats.J Cardiovasc Pharmacal,1 999,33:341-345.
  • 4Obeta J,Nakamura T,Kuroyanagi R,et al.Candesartan prevents the progression of glomerulosclerosis in genetic hypertensive rats.Kidney Int,1997,(52 Suppl)63:S229-S231.
  • 5刘娅,卢义侠.洛汀新对大鼠阿霉素肾病的保护作用[J].江苏医药,1999,25(1):28-29. 被引量:2
  • 6程震,刘志红,唐政,胡伟新,陈朝红,俞雨生,陈惠萍,黎磊石.肾素-血管紧张素系统基因多态性对血管紧张素Ⅱ受体阻断剂降低尿蛋白疗效的影响[J].肾脏病与透析肾移植杂志,2003,12(4):307-312. 被引量:4

二级参考文献23

  • 1陈朝红,刘志红,王庆文,季曙明,季大玺,黎磊石.血管紧张素转化酶基因多态性在终末期肾功能衰竭患者中的分布及其意义[J].中华肾脏病杂志,1997,13(1):22-24. 被引量:15
  • 2林善琰.-[J].肾脏病与透析肾移植杂志,1993,2(2):127-127.
  • 3Kainulainen K,Perola M,Terwilliger J,et al.Evidence for involvement of teh type 1 angiotensin Ⅱ receptor locus in essential hypertension.Hypertension,1999,33:844
  • 4Caulfield M, Lavender P, Farrall M, et al.Linkage of the angiotensinogen gene to essential hypertension. New Engl J Med, 1994, 330(23):1629.
  • 5Bloem LJ, Manatunga A, Tewkesbury DA, et al. The serum angiotensinogen concentration and variants of the angiotensinogen gene in black and white children.J Clin Invest,1995,95:948
  • 6Yeshida H, Mitarai T, Kawamura T, et al. Role of the deletion polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy J Clin Invest, 1995, 96:2162.
  • 7Kurland L, Melhus H, Karlsson J, et al. Angiotensin convesting enzyme gene polymorphism predicts blood pressure response to angiotensin Ⅱ receptor type 1 antagonist treatment in hypertensive patients. Hypertension,2001, 19(10): 1 783.
  • 8Andersen S, Tamow L, Cambien F, et al. Renoprotective effects of losartan in diabetic nephropathy: Interaction with ACE insertion/deletion genotype? Kidney Int,2002,62,192.
  • 9Miller JA, Thai K,Scholey JW. Angiotensin Ⅱ type 1 receptor gene polymorphism predicts response to losartan and angiotensin Ⅱ. Kidney Int,1999,56:2 173.
  • 10Furuta H, Deng-Fu Guo,Inagami T. Molecular cloning and sequencing of the gene encoding human angiotensin Ⅱ type Ⅰ receptor. Biochem Biophs Res Commun, 1992,183(1) :8.

共引文献4

同被引文献10

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部